Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMD

Ophthalmology. 2017 Feb;124(2):270-272. doi: 10.1016/j.ophtha.2016.08.013. Epub 2016 Sep 3.

Authors

Hessom Razavi¹, Richard Walton², Mark Gillies², Robyn Guymer³; Fight Retinal Blindness! Project Investigators

Affiliations

¹ Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Australia; Ophthalmology, Department of Surgery, University of Melbourne, Australia. Electronic address: [email protected].
² Save Sight Institute, Sydney Medical School, The University of Sydney, Australia.
³ Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Australia; Ophthalmology, Department of Surgery, University of Melbourne, Australia.

PMID: 27596290
DOI: 10.1016/j.ophtha.2016.08.013

No abstract available

Publication types

Review

MeSH terms

Angiogenesis Inhibitors / administration & dosage*
Disease Progression
Follow-Up Studies
Humans
Intravitreal Injections
Prognosis
Time Factors
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
Visual Acuity / physiology*
Wet Macular Degeneration* / diagnosis
Wet Macular Degeneration* / drug therapy
Wet Macular Degeneration* / physiopathology

Substances

Angiogenesis Inhibitors
Vascular Endothelial Growth Factor A